Home › Core › ISCC-IDs › 28C6ePNfrgysd

View ISCC-ID

Core Data

28C6ePNfrgysd
ISCC-ID - digital asset identifier
CCMp7qHRHf2EK-CTavhn26fZW5M-CDaXAHpGbY3yX-CRG8fwVx6HtgK
ISCC-CODE - digital asset descriptor
2QTa5N4aeSrCB2MLoPdPF4AsTjstJgcLTnd
PUBLIC-KEY or WALLET-ADDRESS of DECLARING PARTY
0
Number of times updated

Seed Metadata (Immutable)

clinical and health care use characteristics of patients newly starting allopurinol febuxostat and colchicine for the treatment

Ledger Reference

coblo
Source Ledger/Blockchain
8715
N-th ISCC Decleration on source ledger
3477ae215173efea345b2ba2e55a3d807dbc1e844957abbba038d648213703c4
Hash of block that includes the ISCC-DECLARATION
59ec60326247d9472dbff74bb01e01d26994a0a7f46bd7d0bb4b88e910602955
Hash of transaction that includes the ISCC-DECLERATION
0
Output index that includes ISCC-DECLERATION (UTXO based chains)

Mutable Metadata

[{"data": {"name": "Clinical and Health Care Use Characteristics of Patients Newly Starting Allopurinol, Febuxostat, and Colchicine for the Treatment of Gout", "@type": "ScholarlyArticle", "genre": "journal-article", "author": [{"name": "Seoyoung C. Kim", "@type": "Person"}, {"name": "Bernhard M. W. Schmidt", "@type": "Person"}, {"name": "Jessica M. Franklin", "@type": "Person"}, {"name": "Jun Liu", "@type": "Person"}, {"name": "Daniel H. Solomon", "@type": "Person"}, {"name": "Sebastian Schneeweiss", "@type": "Person"}], "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "http://europepmc.org/articles/pmc4096791?pdf=render", "encodingFormat": "application/pdf"}], "publisher": {"name": "Wiley-Blackwell", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.1002/acr.22067", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CCMp7qHRHf2EK-CTavhn26fZW5M-CDaXAHpGbY3yX-CRG8fwVx6HtgK", "propertyID": "ISCC"}], "datePublished": "2013-11-27"}, "schema": "schema.org", "mediatype": "application/ld+json"}]
Close